Atlas Trials

Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL

Clinical trial NCT00529360 · COMPLETED

Trial details

NCT number
NCT00529360
Sponsor
New York Medical College
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaAcute Myelogenous Leukemia
Start date
2007-06-01
Primary completion
2016-01-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.